BioNTech SE (BNTX) Return on Capital Employed (2019 - 2025)

BioNTech SE has disclosed Return on Capital Employed across 7 years of filings, most recently posting 6.85% for Q4 2025.

• Return on Capital Employed for Q4 2025 came in at 6.85%, down 28.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 6.85% (down 28.0% YoY), and the FY2025 annual result was 7.2%, down 74.0% from the prior year.
• Return on Capital Employed came in at 6.85% for Q4 2025 at BioNTech SE, down from 4.63% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 178.73% in Q2 2021 to a low of 6.85% in Q4 2025.
• The 5-year median for Return on Capital Employed is 21.27% (2023), against an average of 50.52%.
• Across the five-year window, Return on Capital Employed jumped 20528 bps in 2021 and slumped 9234 bps in 2023, its largest moves.
• BioNTech SE's Return on Capital Employed stood at 133.74% in 2021, then tumbled by 50 bps to 66.34% in 2022, then tumbled by 95 bps to 3.3% in 2023, then plunged by 299 bps to 6.57% in 2024, then slipped by 4 bps to 6.85% in 2025.
• The last three Return on Capital Employed figures came in at 6.85% (Q4 2025), 4.63% (Q3 2025), and 4.5% (Q2 2025), per Business Quant data.